NEO 16.16 (-0.8%)
US64049M2098Medical Diagnostics & ResearchDiagnostics & Research

NeoGenomics (NEO) Stock Highlights

16.16 | -0.8%
2024-09-19 02:21:43
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.

Statistics

Range Today
16.12 16.68
Volume Today 484.2K
Range 1 Year
11.03 21.22
Volume 1 Year 221.59M
Range 3 Year
6 54.74
Volume 3 Year 892.41M
Range 10 Year
3.33 61.57
Volume 10 Year 1.93B

Highlights

Market Capitalization 2.1B (mid)
Floating Shares 126.41M
Current Price 16.16
Price To Earnings -26.68
Price To Revenue 3.69
Price To Book 2.29
Earnings Per Share -0.62
Payout Ratio 0%

Performance

Latest -0.8%
1 Month -0.55%
3 Months +23.83%
6 Months +9.63%
1 Year +20.33%
3 Years -65.82%
5 Years -24.98%
10 Years +197.61%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.